Literature DB >> 8260354

Stopping rules, interim analyses and data monitoring committees.

D Ashby, D Machin.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  1993        PMID： 8260354      PMCID： PMC1968643          DOI： 10.1038/bjc.1993.481

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  25 in total

1.  Equipoise and the ethics of clinical research.

Authors:  B Freedman
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

2.  Statistical problems in the reporting of clinical trials. A survey of three medical journals.

Authors:  S J Pocock; M D Hughes; R J Lee
Journal:  N Engl J Med       Date:  1987-08-13       Impact factor: 91.245

3.  Terminating a trial -- the ethical problem.

Authors:  P Meier
Journal:  Clin Pharmacol Ther       Date:  1979-05       Impact factor: 6.875

4.  Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.

Authors:  N L Geller; S J Pocock
Journal:  Biometrics       Date:  1987-03       Impact factor: 2.571

5.  Role of the pharmaceutical industry in major clinical trials.

Authors:  J R Hampton; D G Julian
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

6.  Treatment of stage-II carcinoma of the female breast.

Authors:  D Brinkley; S L Haybittle
Journal:  Lancet       Date:  1966-08-06       Impact factor: 79.321

7.  Treatment of early breast cancer: a report after ten years of a clinical trial.

Authors:  H Atkins; J L Hayward; D J Klugman; A B Wayte
Journal:  Br Med J       Date:  1972-05-20

8.  Interim analyses and stopping rules in cancer clinical trials.

Authors:  J Whitehead
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

9.  A simulated sequential analysis based on data from two MRC trials.

Authors:  A N Donaldson; J Whitehead; R Stephens; D Machin
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

10.  Size of cancer clinical trials and stopping rules.

Authors:  S J Pocock
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640
View more
  3 in total

Review 1.  Monitoring clinical trials--interim data should be publicly available.

Authors:  R J Lilford; D Braunholtz; S Edwards; A Stevens
Journal:  BMJ       Date:  2001-08-25

2.  Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction.

Authors:  Anouk Pels; Janus C Jakobsen; Wessel Ganzevoort; Christiana A Naaktgeboren; Wes Onland; Aleid G van Wassenaer-Leemhuis; Christian Gluud
Journal:  Trials       Date:  2019-01-11       Impact factor: 2.279

3.  Methodology Series Module 4: Clinical Trials.

Authors:  Maninder Singh Setia
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.